Related Experiment Videos
Modulation of doxorubicin cytotoxicity by ethacrynic acid
1Department of Internal Medicine, University of Texas Medical Branch, Galveston 77555, USA.
Abstract:
Energy-dependent membrane efflux pumps have been implicated in mediating resistance to doxorubicin (DOX). Membrane-transport mechanisms distinct from P-glycoprotein, capable of transporting DOX and glutathione conjugates have been reported in human cells. Since glutathione-conjugate-forming compounds may be candidates for modulating the cytotoxicity of certain anti-neoplastic agents transported by such transport mechanism, the present studies were performed (i) to determine whether ethacrynic acid, a glutathione-conjugate-forming diuretic, can increase DOX cytotoxicity, and (ii) to study the kinetics of DOX transport and its inhibition by the glutathione conjugate of ethacrynic acid (EA-SG) in the H69 human small-cell-lung-cancer cell line and 2 derived DOX-resistant sublines. Our results indicate that more than one DOX transport mechanism may exist in these cell lines, and that glutathione conjugates may be useful for modulating the cytotoxic effects of DOX.
Insights
Ethacrynic acid may enhance doxorubicin (DOX) cancer cell killing. Glutathione conjugates, like ethacrynic acid-glutathione conjugate (EA-SG), show potential for modulating anti-cancer drug efficacy.
Area of Science:
- Pharmacology
- Cancer Biology
- Drug Resistance
Background:
- Energy-dependent membrane efflux pumps contribute to doxorubicin (DOX) resistance.
- Human cells possess DOX and glutathione conjugate transport mechanisms independent of P-glycoprotein.
Purpose of the Study:
- To investigate if ethacrynic acid (EA), a glutathione-conjugate-forming diuretic, enhances DOX cytotoxicity.
- To examine the kinetics of DOX transport and its inhibition by ethacrynic acid-glutathione conjugate (EA-SG).
- To study these effects in H69 human small-cell lung cancer cells and DOX-resistant variants.
Main Methods:
- Cell culture of H69 human small-cell lung cancer line and its doxorubicin-resistant sublines.
- Assessment of doxorubicin cytotoxicity following treatment with ethacrynic acid.
- Kinetic analysis of doxorubicin transport and inhibition by ethacrynic acid-glutathione conjugate (EA-SG).
Main Results:
- Ethacrynic acid demonstrated the potential to increase doxorubicin cytotoxicity.
- Evidence suggests the existence of multiple doxorubicin transport mechanisms within the studied cell lines.
- The glutathione conjugate of ethacrynic acid (EA-SG) influenced doxorubicin transport kinetics.
Conclusions:
- Multiple doxorubicin transport pathways may operate in human small-cell lung cancer cells.
- Glutathione conjugates, such as EA-SG, show promise as modulators of doxorubicin's cytotoxic effects.
- Targeting these transport mechanisms could offer strategies to overcome drug resistance in cancer therapy.